Whole genome sequencing shows promise in routine treatment of blood cancers, Washington U. study says

View Content

Michele Munz

ST. LOUIS — Washington University researchers are among the first to show that whole genome sequencing, which used to be time-consuming and expensive, can be used routinely in patient care.

Print Friendly, PDF & Email